Gulf Coast Consortium for Innovative Drug Discovery and Development
Formerly the John S. Dunn Gulf Coast Consortium for Chemical Genomics (GCC CG) which was formed in 2003, the Consortium for Innovative Drug Discovery and Development (GCC IDDD) is a research consortium focused on providing support for Houston/Galveston scientists in advancing their therapeutics discoveries through development to the clinic. IDDD support includes collaborative networking and joint funding opportunities, shared core resources, and educational programs.
New! The Cancer Therapeutics Training Program (CTTP)
The Cancer Therapeutics Training Program (CTTP) is a multi-institutional post-doctoral training program designed to prepare post-doctoral trainees for future careers in academic and/or commercial cancer therapeutics research and development (R&D). The goal of the program is to recruit and train scientists equipped with the essential skills and knowledge necessary to translate basic cancer research discoveries into commercially viable cancer therapeutics. For more information, visit the CTTP Website.
News
Thank you to everyone who helped make our Kickoff Mini-Symposium a success! For speaker and panel videos, Click Here.
Upcoming Events
GCC IDDD and BioHouston BioConnect, March 4, 2025
This event is open to all healthcare technology innovators, entrepreneurs, and biotech stakeholders. BioConnect promotes collaboration among academic and industry innovators and key stakeholders within our growing biotech ecosystem. Each […]
GCC IDDD Round Table Workshop: Peptide Drug Development and Delivery
Presented by the GCC Innovative Drug Discovery, the GCC Cancer Therapeutics Training Program (CTTP), and the GCC Innovative Drug Discovery and Development Scholars Program, we invite you to register for the March GCC IDDD Round […]
6th Annual GCC Innovative Drug Discovery and Development Conference
Confirmed Keynote presenters are Michelle Arkin, Univ. of California, San Francisco, and Miguel Hernán, Harvard Univ.
